Hereditary cancer testing |How it Works
The HerediGENE® test is performed by analyzing 43 genes involved in the genetic predisposition to cancer, 17 of which are related to the Homologous Recombination (HR) complex. The content of the analysis covers the most important genes associated with hereditary predisposition to cancer.
The Technology of HerediGENE®
HerediGENE® test is designed to achieve maximum sensitivity and specificity. Sequencing is performed through the Illumina platform using advanced Next Generation Sequencing (NGS) technology to fully analyze a group of genes associated with inherited cancer syndromes. Analysis of large genomic rearrangements is also included in HerediGENE.
The vast majority of individuals who receive a positive finding from the HerediGENE analysis will receive results for which there are already available guidelines for the individualized clinical management of the subject.